Council Foundation Logo Leaders Edge
Surprise Billing and Industry Transparency
Prescription Drug Pricing | Jul. 17, 2019

July 18, 2019 The House Energy and Commerce Committee’s Subcommittee on Health recently marked up and voted in favor of drug transparency and surprise billing legislation. No Surprises Act (H.R.

The Administration Tosses Drug Rebating Rule
Prescription Drug Pricing | Jul. 17, 2019

July 18, 2019 The Trump administration announced it will not pursue its proposal to eliminate prescription drug rebates from government-facilitated health plans. While once touted as a critical step in

Healthcare Reform: Legislation Trackers
Prescription Drug Pricing | Jun. 20, 2019

June 20, 2019 Our legal team at Steptoe & Johnson tracks healthcare reform bills in the 116th Congress. These documents are updated as of June 14. Federal Healthcare Reform Tracker.

Back Door Discounts
Prescription Drug Pricing | May. 16, 2019

The pharmacy supply chain is one of the most complex and opaque parts of the healthcare ecosystem. Co-pay discounts and other rebates may lower costs, but do not address the

Government Affairs Roundup: The Latest on Healthcare Policy
Prescription Drug Pricing | May. 16, 2019

Surprise Medical Billing Broad bipartisan support from the Trump administration as well as Congress has created momentum around surprise medical billing. Earlier this week, the House Energy and Commerce Committee

Next Page »